Leadership Board of Directors Our Culture In Memoriam
Our Approach Scientific Publications
Pipeline Our Programs Expanded Access
OVERVIEW PRESS RELEASES EVENTS & PRESENTATIONS STOCK INFORMATION SEC FILINGS CORPORATE GOVERNANCE EMAIL ALERTS
 

Taking the journey towards comprehensive treatment of SERIOUS DISEASE

 
 
new-approach.jpg

RECENT NEWS

darkblue.jpg

OUR THERAPEUTIC PROGRAMS

We are a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases including oncology and obesity.